Keyphrases
Monoclonal Antibody
100%
Epitope
100%
Zika Virus
100%
Dengue Virus Envelope
100%
Dengue Patients
100%
Dengue Virus
53%
Virus
23%
Flavivirus
23%
Immune Serum
23%
Pregnant Women
15%
Dengue Infection
15%
Zika Virus Infection
15%
Protective Immunity
7%
Murine Model
7%
Cell Culture
7%
Virus Vaccine
7%
Life-threatening
7%
Reinfection
7%
South America
7%
Brazil
7%
Virus Strains
7%
Severe Disease
7%
Neurological Diseases
7%
Birth Defects
7%
Disease Potential
7%
Long-term Immunity
7%
Emerging Arboviruses
7%
Neutralizing Antibodies
7%
Immunotherapeutics
7%
Effective Concentration
7%
EC50
7%
Cytomegalovirus
7%
Dengue Virus Serotype 2
7%
Cross-reactive Antibodies
7%
Mosquito-borne Flavivirus
7%
Human Antibody
7%
Rubella Virus
7%
Transmission Potential
7%
Fetal Malformations
7%
Cross-neutralizing Antibody
7%
Guillain-Barré Syndrome
7%
Nine-level
7%
Fetal Loss
7%
Human Pathogenic
7%
Microcephaly
7%
Antibody Therapy
7%
Conserved Epitopes
7%
Repurposing
7%
Flavivirus Diagnostics
7%
Immunotherapeutic Approaches
7%
Zika Virus Transmission
7%
Immunology and Microbiology
Monoclonal Antibody
100%
Epitope
100%
Viral Envelope
100%
Dengue Fever
100%
Dengue Virus
100%
Zika Virus
100%
Flavivirus
33%
Immunology
26%
Viral Disease
20%
Human Monoclonal Antibody
20%
Antiserum
20%
Neutralizing Antibody
13%
EC50
13%
Cell Culture
6%
Serotype
6%
Arbovirus
6%
Virus Strain
6%
Dilution
6%
Cytomegalovirus
6%
Cross Reacting Antibody
6%
Rubella Virus
6%
Dengue Vaccine
6%
Guillain-Barré Syndrome
6%